Concentrix Corporation Common Stock earnings per share and revenue
On Jan 13, 2026, CNXC reported earnings of 2.95 USD per share (EPS) for Q4 25, missing the estimate of 2.96 USD, resulting in a -0.61% surprise. Revenue reached 2.55 billion, compared to an expected 2.59 billion, with a -1.43% difference. The market reacted with a -3.21% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of 2.69 USD, with revenue projected to reach 2.54 billion USD, implying an decrease of -8.81% EPS, and decrease of -0.43% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Healthcare Services Group
Report Date
Feb 11, 2026 For Q4 25
Estimate
$0.23
Actual
$0.44
Surprise
+87.55%
AMN Healthcare Services
Report Date
Feb 19, 2026 For Q4 25
Estimate
$0.28
Actual
$0.22
Surprise
-21.51%
UL Solutions Inc.
Report Date
Feb 19, 2026 For Q4 25
Estimate
$0.45
Actual
$0.53
Surprise
+16.61%
BRIGHT HORIZONS FAMILY SOLUTIONS INC.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$1.14
Actual
$1.14
Surprise
+0.51%
SPS Commerce, Inc.
Report Date
Feb 12, 2026 For Q4 25
Estimate
$1.02
Actual
$1.13
Surprise
+10.84%
FAQ
What were Concentrix Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Concentrix Corporation Common Stock reported EPS of $2.95, missing estimates by -0.61%, and revenue of $2.55B, -1.43% below expectations.
How did the market react to Concentrix Corporation Common Stock's Q4 2025 earnings?
The stock price moved down -3.21%, changed from $40.48 before the earnings release to $39.18 the day after.
When is Concentrix Corporation Common Stock expected to report next?
The next earning report is scheduled for Mar 24, 2026.
What are the forecasts for Concentrix Corporation Common Stock's next earnings report?
Based on 5
analysts, Concentrix Corporation Common Stock is expected to report EPS of $2.69 and revenue of $2.54B for Q1 2026.